UZH-Logo

Maintenance Infos

Evidence and efficacy: lipid modifying therapy


Evidence and efficacy: lipid modifying therapy. Edited by: von Eckardstein, A (2010). Suffolk, UK: Cedilla.

Abstract

Hyperlipidaemia is an important risk factor for the pathogenesis of atherosclerotic vascular diseases, especially CHD. In addition to lifestyle changes, several drugs have been investigated in controlled clinical trials for their ability to correct dyslipidaemia and reduce CV morbidity and mortality. Notably, statins, which inhibit HMG CoA reductase and hence cholesterol synthesis, are very effective in reducing plasma levels of LDL cholesterol and help to reduce CV event rates. Since the early 1990s, this class of drugs has proved to be very successful in both primary and secondary prevention trials, encompassing >500,000 patient years of follow-up.

Evidence & Efficacy: Lipid-Modifying Therapy aims to provide a convenient collection of the most important controlled clinical trials in the treatment of dyslipidaemia and prevention of CV disease.

Hyperlipidaemia is an important risk factor for the pathogenesis of atherosclerotic vascular diseases, especially CHD. In addition to lifestyle changes, several drugs have been investigated in controlled clinical trials for their ability to correct dyslipidaemia and reduce CV morbidity and mortality. Notably, statins, which inhibit HMG CoA reductase and hence cholesterol synthesis, are very effective in reducing plasma levels of LDL cholesterol and help to reduce CV event rates. Since the early 1990s, this class of drugs has proved to be very successful in both primary and secondary prevention trials, encompassing >500,000 patient years of follow-up.

Evidence & Efficacy: Lipid-Modifying Therapy aims to provide a convenient collection of the most important controlled clinical trials in the treatment of dyslipidaemia and prevention of CV disease.

Altmetrics

Additional indexing

Item Type:Edited Scientific Work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Clinical Chemistry
Dewey Decimal Classification:610 Medicine & health
540 Chemistry
Language:English
Date:2010
Previous Dates:25 February 2008
Deposited On:27 Feb 2009 12:43
Last Modified:05 Apr 2016 13:04
Publisher:Cedilla
Volume:1
Number of Pages:128
ISBN:978-1905982035
Official URL:http://www.cedillapublishing.com/ee-lmt.php

Download

Full text not available from this repository.

TrendTerms

TrendTerms displays relevant terms of the abstract of this publication and related documents on a map. The terms and their relations were extracted from ZORA using word statistics. Their timelines are taken from ZORA as well. The bubble size of a term is proportional to the number of documents where the term occurs. Red, orange, yellow and green colors are used for terms that occur in the current document; red indicates high interlinkedness of a term with other terms, orange, yellow and green decreasing interlinkedness. Blue is used for terms that have a relation with the terms in this document, but occur in other documents.
You can navigate and zoom the map. Mouse-hovering a term displays its timeline, clicking it yields the associated documents.

Author Collaborations